株式会社極東書店トップ ＞ 商品一覧 ＞ Advanced Statistics in Regulatory Critical Clinical Initiatives.
商品詳細
Advanced Statistics in Regulatory Critical Clinical Initiatives.
・ISBN 978-0-367-56178-9 hard GB£ 187.99
￥59,555.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
電子版あり 大学・学術機関向け電子ブック（eBook）ISBN 978-1-003-10732-3
| 著者・編者 | Zhang, Wei / Yan, Fangrong / Chen, Feng / Chow, Shein-Chung (eds.), |
|---|---|
| シリーズ | Chapman & Hall/CRC Biostatistics Series |
| 出版社 | (Chapman & Hall/CRC, UK) |
| 出版年月 | 2022 |
| ページ数 | 307 pp. |
| 言語 | ENG |
| ニュース番号 | ＜M25-13365＞ |
解説
Advanced Statistics in Regulatory Critical Clinical Initiatives is focused on the critical clinical initiatives introduced by the 21st Century Cure Act passed by the United States Congress in December 2016. The book covers everything from the outline of the initiatives to analysis on the effect on biopharmaceutical research and development. Advanced Statistics in Regulatory Critical Clinical Initiatives provides innovative ways to resolve common challenges in statistical research of rare diseases such small sample sizes and provides guidance for combined use of data. With analysis from regulatory and scientific perspectives this book is an ideal companion for researchers in biostatistics, pharmaceutical development, and policy makers in related fields.
Key Features:
- Provides better understanding of innovative design and analysis of each critical clinical initiatives which may be used in regulatory review/approval of drug development.
- Makes recommendations to evaluate submissions accurately and reliably.
- Proposes innovative study designs and statistical methods for oncology and/or rare disease drug development.
- Provides insight regarding current regulatory guidance on drug development such as gene therapy and rare diseases.